Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wadler

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Seminars in Oncology|December 22, 1999
Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancerD Makower, S Wadler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Role of interferon as a modulator of fluoropyrimidines: reply to a recent editorialS Wadler, E L Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulationS Wadler, E L Schwartz
Seminars in Oncology|February 1, 1990
Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinomaS Wadler, P H Wiernik
Molecular Pharmacology|December 1, 1991
Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolinsS Wadler, C P Yang
Cancer Research|February 1, 1988
Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variantsS Wadler, P H Wiernik
Cancer Research|June 15, 1990
Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a reviewS Wadler, E L Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Interferons as biochemical modulatorsE C Borden, S Wadler
Advances in Experimental Medicine and Biology|January 1, 1993
Increasing the efficacy of 5-fluorouracil with interferons: preclinical, clinical, and pharmacokinetic studiesJ A Sparano, S Wadler
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferonS Wadler, E L Schwartz
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Seminars in Oncology|December 22, 1999
Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancerD Makower, S Wadler
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Role of interferon as a modulator of fluoropyrimidines: reply to a recent editorialS Wadler, E L Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulationS Wadler, E L Schwartz
Seminars in Oncology|February 1, 1990
Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinomaS Wadler, P H Wiernik
Molecular Pharmacology|December 1, 1991
Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolinsS Wadler, C P Yang
Cancer Research|February 1, 1988
Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variantsS Wadler, P H Wiernik
Cancer Research|June 15, 1990
Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a reviewS Wadler, E L Schwartz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Interferons as biochemical modulatorsE C Borden, S Wadler
Advances in Experimental Medicine and Biology|January 1, 1993
Increasing the efficacy of 5-fluorouracil with interferons: preclinical, clinical, and pharmacokinetic studiesJ A Sparano, S Wadler
Cancer Chemotherapy and Pharmacology|January 1, 1994
Biologic agents as biochemical modulators: pharmacologic basis for the interaction of cytotoxic chemotherapeutic drugs and interferonS Wadler, E L Schwartz
Pageof 14